checkAd
    Mydecine Innovations Group Aktie
    0,2310
     
    EUR
    0,00 %
    0,0000 EUR
    Letzter Kurs 01.10.21 Tradegate
    0,2215
     
    EUR
    8.000 STK
    Geldkurs 30.09.21
    0,2400
     
    EUR
    7.000 STK
    Briefkurs 30.09.21
    ISIN: CA62848R1064 · WKN: A2P6ED · Kanada

    Neueste Nachrichten

    Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
    10.10.23 · globenewswire · Mydecine Innovations Group
    Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
    05.10.23 · globenewswire · Mydecine Innovations Group
    Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
    27.09.23 · globenewswire · Mydecine Innovations Group
    Mydecine Innovations Announces Amended Press Release Relating to the Closing of Prospectus Supplement Financing
    20.09.23 · globenewswire · Mydecine Innovations Group
    Mydecine Innovations Announces Closing of Prospectus Supplement Financing
    19.09.23 · globenewswire · Mydecine Innovations Group
    Mydecine Innovations Group Files Prospectus Supplement
    15.09.23 · globenewswire · Mydecine Innovations Group
    Mydecine Announces Conditional Approval of CSE Listing
    30.08.23 · globenewswire · Mydecine Innovations Group
    Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2023
    15.08.23 · globenewswire · Mydecine Innovations Group
    Mydecine Innovations Group Provides Corporate Update
    21.07.23 · globenewswire · Mydecine Innovations Group
    Mydecine Reports its Special Meeting Results
    05.07.23 · globenewswire · Mydecine Innovations Group
    Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors
    30.05.23 · globenewswire · Mydecine Innovations Group
    Mydecine Reports Financial Results for the First Quarter of Fiscal Year 2023
    16.05.23 · globenewswire · Mydecine Innovations Group